Kent Jardemark Selected Research

1- (5- chloro- 2- hydroxyphenyl)- 3- (2- chloro- 5- trifluoromethylphenyl)urea

1/2016

Alpha7 nicotinic acetylcholine receptor agonists and PAMs as adjunctive treatment in schizophrenia. An experimental study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kent Jardemark Research Topics

Disease

11	Schizophrenia (Dementia Praecox) 01/2017 - 01/2002
5	Catalepsy 05/2012 - 02/2008
3	Pain (Aches) 01/2021 - 01/2013
3	Cognitive Dysfunction 01/2021 - 05/2012
2	Bipolar Disorder (Manic Depressive Psychosis) 11/2010 - 02/2008
2	Neurobehavioral Manifestations 11/2010 - 02/2008
1	Inflammation (Inflammations) 01/2019
1	Hypersensitivity (Allergy) 01/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 03/2015
1	Alcoholism (Alcohol Abuse) 03/2015
1	Treatment-Resistant Depressive Disorder 10/2014
1	Major Depressive Disorder (Major Depressive Disorders) 07/2013
1	Neurogenic Inflammation 01/2013
1	Weight Gain 08/2010
1	Treatment-Resistant Schizophrenia 08/2010

Drug/Important Bio-Agent (IBA)

7	Antipsychotic Agents (Antipsychotics)IBA 01/2016 - 02/2008
5	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2012 - 08/2010
4	Antidepressive Agents (Antidepressants)IBA 01/2017 - 08/2010
4	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2016 - 08/2010
4	Dopamine (Intropin)FDA LinkGeneric 04/2012 - 01/2002
3	Clozapine (Clozaril)FDA LinkGeneric 01/2017 - 01/2002
3	asenapine FDA Link 10/2014 - 02/2008
2	AntibodiesIBA 01/2021 - 01/2019
2	Nicotine FDA Link 01/2016 - 06/2005
2	Pharmaceutical PreparationsIBA 11/2010 - 01/2002
2	Therapeutic UsesIBA 08/2010 - 08/2010
2	N-Methylaspartate (NMDA)IBA 08/2010 - 08/2010
1	Kynurenic Acid (Kynurenate)IBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	KynurenineIBA 01/2021
1	AutoantibodiesIBA 01/2019
1	AntigensIBA 01/2019
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2019
1	Cartilage Oligomeric Matrix ProteinIBA 01/2019
1	Collagen Type II (Type II Collagen)IBA 01/2019
1	brexpiprazoleIBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2016
1	1- (5- chloro- 2- hydroxyphenyl)- 3- (2- chloro- 5- trifluoromethylphenyl)ureaIBA 01/2016
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2016
1	PNU-282987IBA 01/2016
1	alpha7 Nicotinic Acetylcholine ReceptorIBA 01/2016
1	AntioxidantsIBA 01/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016
1	Guanfacine (Tenex)FDA LinkGeneric 03/2015
1	CatecholaminesIBA 10/2014
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 10/2014
1	Quetiapine Fumarate (Seroquel)FDA Link 07/2013
1	CholesterolIBA 01/2013
1	Ion Channels (Ion Channel)IBA 01/2013
1	1-(benzofurazan-5-ylcarbonyl)piperidineIBA 05/2012
1	propionic acid (potassium propionate)IBA 05/2012
1	Org 26576IBA 05/2012
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 05/2012
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 05/2012
1	N- methyl- N- (6- methoxy- 1- phenyl- 1,2,3,4- tetrahydronaphthalen- 2- ylmethyl)aminomethylcarboxylic acidIBA 05/2012
1	AMPA Receptors (AMPA Receptor)IBA 05/2012
1	Escitalopram FDA Link 04/2012
1	Citalopram FDA LinkGeneric 04/2012
1	Reboxetine (Vestra)IBA 08/2010
1	IdazoxanIBA 08/2010
1	Olanzapine (Zyprexa)FDA Link 08/2010

Therapy/Procedure

1	Therapeutics 01/2019
1	Drug Tapering 08/2010
1	Self Medication 06/2005